These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 34912782)
41. Variable selection based QSAR modeling on Bisphenylbenzimidazole as Inhibitor of HIV-1 reverse transcriptase. Kumar S; Tiwari M Med Chem; 2013 Nov; 9(7):955-67. PubMed ID: 23106285 [TBL] [Abstract][Full Text] [Related]
42. Development of linear and nonlinear predictive QSAR models and their external validation using molecular similarity principle for anti-HIV indolyl aryl sulfones. Roy K; Mandal AS J Enzyme Inhib Med Chem; 2008 Dec; 23(6):980-95. PubMed ID: 18608761 [TBL] [Abstract][Full Text] [Related]
43. Quantitative structure-activity relationship (QSAR) study of interleukin-1 receptor associated kinase 4 (IRAK-4) inhibitor activity by the genetic algorithm and multiple linear regression (GA-MLR) method. Pourbasheer E; Riahi S; Ganjali MR; Norouzi P J Enzyme Inhib Med Chem; 2010 Dec; 25(6):844-53. PubMed ID: 20429783 [TBL] [Abstract][Full Text] [Related]
44. 2D and 3D QSAR models for identifying diphenylpyridylethanamine based inhibitors against cholesteryl ester transfer protein. Chen M; Yang X; Lai X; Gao Y Bioorg Med Chem Lett; 2015 Oct; 25(20):4487-95. PubMed ID: 26346366 [TBL] [Abstract][Full Text] [Related]
50. In silico prediction of dermal penetration rate of chemicals from their molecular structural descriptors. Fatemi MH; Malekzadeh H Environ Toxicol Pharmacol; 2012 Sep; 34(2):297-306. PubMed ID: 22659232 [TBL] [Abstract][Full Text] [Related]
51. Activity of Metal-Azole Complexes Against Biofilms of Pereira LD; Vila T; Borba-Santos LP; de Souza W; Navarro M; Rozental S Curr Pharm Des; 2020; 26(14):1524-1531. PubMed ID: 32065088 [TBL] [Abstract][Full Text] [Related]
52. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment. Jensen RH Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142 [TBL] [Abstract][Full Text] [Related]
53. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Sanglard D; Ischer F; Monod M; Bille J Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():405-416. PubMed ID: 9043118 [TBL] [Abstract][Full Text] [Related]
54. Respiratory deficiency enhances the sensitivity of the pathogenic fungus Candida to photodynamic treatment. Chabrier-Roselló Y; Foster TH; Mitra S; Haidaris CG Photochem Photobiol; 2008; 84(5):1141-8. PubMed ID: 18248505 [TBL] [Abstract][Full Text] [Related]
55. Germ tube growth of Candida albicans. Gow NA Curr Top Med Mycol; 1997 Dec; 8(1-2):43-55. PubMed ID: 9504066 [TBL] [Abstract][Full Text] [Related]
56. Modulation of morphogenesis in Candida albicans by various small molecules. Shareck J; Belhumeur P Eukaryot Cell; 2011 Aug; 10(8):1004-12. PubMed ID: 21642508 [TBL] [Abstract][Full Text] [Related]
57. Modulation of Candida albicans virulence in in vitro biofilms by oral bacteria. Morse DJ; Wilson MJ; Wei X; Bradshaw DJ; Lewis MAO; Williams DW Lett Appl Microbiol; 2019 Apr; 68(4):337-343. PubMed ID: 30825340 [TBL] [Abstract][Full Text] [Related]
58. Relative Abundances of Candida albicans and Candida glabrata in Olson ML; Jayaraman A; Kao KC Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29427422 [No Abstract] [Full Text] [Related]
59. Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives. Fassihi A; Abedi D; Saghaie L; Sabet R; Fazeli H; Bostaki G; Deilami O; Sadinpour H Eur J Med Chem; 2009 May; 44(5):2145-57. PubMed ID: 19056147 [TBL] [Abstract][Full Text] [Related]
60. Inhibitory Effect of Resveratrol on Candida albicans Biofilm Formation. Okamoto-Shibayama K; Yoshida A; Ishihara K Bull Tokyo Dent Coll; 2021 Mar; 62(1):1-6. PubMed ID: 33583879 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]